Mechanisms of Particulate Matter Induced Dendritic Cell Activation
颗粒物诱导树突状细胞激活的机制
基本信息
- 批准号:8294888
- 负责人:
- 金额:$ 53.39万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2011
- 资助国家:美国
- 起止时间:2011-07-01 至 2014-06-30
- 项目状态:已结题
- 来源:
- 关键词:A/J MouseAdoptive TransferAirAirborne Particulate MatterAllergicAntigen PresentationAntigensAromatic HydrocarbonsAsthmaAttentionBaltimoreBreathingCD4 Positive T LymphocytesCell physiologyCellsChildChildhood AsthmaChronicComplex MixturesDataDendritic CellsDendritic cell activationDevelopmentDiseaseDisease susceptibilityEndotoxinsEnvironmentEnvironmental Risk FactorEpidemiologyEpithelial CellsEpitheliumExposure toExtrinsic asthmaFungal ComponentsGeneticGenetically Engineered MouseGoalsHealthHumanITGAM geneITGAX geneIn VitroInbreedingIndividualInterventionLifeLungMediatingMetalsMolecularMorbidity - disease rateMouse StrainsMusMyelogenousOnset of illnessOxidantsOxidative StressOxidative Stress PathwayParticulate MatterPathway interactionsPattern recognition receptorPhenotypePlayPredispositionPrevalenceProcessProductionRecruitment ActivityRegulationRelative (related person)Research DesignResearch PersonnelResistanceRoleSignal TransductionSocietiesSourceStressSurfaceSymptomsT cell differentiationT-LymphocyteTestingTranslationsairway hyperresponsivenessairway inflammationallergic responsebasechemokineclinical applicationcytokinedectin 1environmental particulateeosinophilic inflammationimmunogenicimmunogenicityin vivoinhibitor/antagonistinner cityinsightnovelpollutantprogramsrespiratoryresponse
项目摘要
Numerous studies have shown a strong association between exposure to airborne particulate matter
(PM) and indicators of asthma. However, the mechanisms underlying this association remain unknown.
Utilizing murine strains of mice, we have demonstrated that exposure to real world particulate matter
induces allergic responses in some strains (A/J) of mice, while not in others (C3H/HeJ). Our preliminary
studies suggest that PM exposure may confer susceptibility to asthma symptoms by altering dendritic cell
(DC) phenotype and function. Specifically, we have made the novel observation that PM alters the
relative proportion of immunogenic myeloid DC to tolerogenic plasmacytoid DC recruited to the lungs of
susceptible A/J mice. Although the mechanisms by which AUB regulates DC function are unknown, our
preliminary data suggests the following hypothesis: that ambient PM induces the allergic response via
activation of dendritic cells through synergistic oxidant and pattern recognition receptor-
dependent (PRRs) pathways. To test this hypothesis, we propose the following aims: 1) To determine
the molecular mechanisms by which PM-induces epithelial cell chemokine production and DC
recruitment, we will test the hypothesis that PM induces epithelial cell chemokine production and DC
recruitment and maturation via oxidative stress pathways; 2) To determine the exact mechanisms by
which PM alters DC cell phenotype, maturation and T cell stimulatory ability in vitro, we will evaluate the
contribution of oxidative stress and pattern recognition receptor pathways (TLRs and dectin-1) to PM-
induced alterations in DC phenotype (DC subset, costimulatory molecule expression, cytokine
production, stimulation of CD4+T cells) in susceptible and resistant murine strains using a combination of
approaches (i.e. pharmacological inhibitors, genetically engineered mice); and 3) To determine the
contribution of AUB-activated DC subsets to susceptibility to the development of allergic airway
responses in murine strains (A/J, C3H) in vivo, we will test the hypothesis that genetic differences in
activation of oxidant and/or pattern recognition receptors (TLRs, dectin-1) contribute to altered activation
of DC and subsequent development of the AUB-induced allergic phenotype. Taken together with the
results of the other projects, the results of this proposal will provide a better understanding of how
exposures to environmental particulate matter may exacerbate and/or induce airway inflammation and
respiratory morbidity with the ultimate goal of translation of information into clinical applications or
intervention strategies that can be used to reduce the morbidity of childhood asthma.
大量研究表明,暴露于空气中的颗粒物之间存在很强的联系
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Marsha Wills-Karp其他文献
Marsha Wills-Karp的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Marsha Wills-Karp', 18)}}的其他基金
Center for Community Health: Addressing Regional Maryland Environmental Determinants of Disease
社区健康中心:解决马里兰州地区疾病的环境决定因素
- 批准号:
10652256 - 财政年份:2022
- 资助金额:
$ 53.39万 - 项目类别:
Center for Community Health: Addressing Regional Maryland Environmental Determinants of Disease
社区健康中心:解决马里兰州地区疾病的环境决定因素
- 批准号:
10394475 - 财政年份:2022
- 资助金额:
$ 53.39万 - 项目类别:
18th International Congress of Mucosal Immunology (ICMI 2017)
第十八届国际粘膜免疫学大会(ICMI 2017)
- 批准号:
9398538 - 财政年份:2017
- 资助金额:
$ 53.39万 - 项目类别:
Role of allergen-driven epithelial genes in asthma pathogenesis
过敏原驱动的上皮基因在哮喘发病机制中的作用
- 批准号:
8196246 - 财政年份:2011
- 资助金额:
$ 53.39万 - 项目类别:
Epithelial Regulation of Th2 Immune Responses in the Lung
肺中 Th2 免疫反应的上皮调节
- 批准号:
8443938 - 财政年份:2009
- 资助金额:
$ 53.39万 - 项目类别:
Epithelial Regulation of Th2 Immune Responses in the Lung
肺中 Th2 免疫反应的上皮调节
- 批准号:
8509573 - 财政年份:2009
- 资助金额:
$ 53.39万 - 项目类别:
Epithelial Regulation of Th2 Immune Responses in the Lung
肺中 Th2 免疫反应的上皮调节
- 批准号:
7696785 - 财政年份:2009
- 资助金额:
$ 53.39万 - 项目类别:
相似海外基金
Time to ATTAC: Adoptive Transfer of T cells Against gp100+ Cells to treat LAM
ATTAC 时间:针对 gp100 细胞的 T 细胞过继转移来治疗 LAM
- 批准号:
10682121 - 财政年份:2023
- 资助金额:
$ 53.39万 - 项目类别:
Phase I clinical trial of adoptive transfer of autologous folate receptor-alpha redirected CAR T cells for ovarian cancer
自体叶酸受体-α重定向CAR T细胞过继转移治疗卵巢癌的I期临床试验
- 批准号:
10576370 - 财政年份:2022
- 资助金额:
$ 53.39万 - 项目类别:
Phase I clinical trial of adoptive transfer of autologous folate receptor-alpha redirected CAR T cells for ovarian cancer
自体叶酸受体-α重定向CAR T细胞过继转移治疗卵巢癌的I期临床试验
- 批准号:
10387023 - 财政年份:2022
- 资助金额:
$ 53.39万 - 项目类别:
Determining mechanisms of enhanced antitumor efficacy of four-day expanded Th17 cells for adoptive transfer
确定用于过继转移的四天扩增 Th17 细胞增强抗肿瘤功效的机制
- 批准号:
10248409 - 财政年份:2019
- 资助金额:
$ 53.39万 - 项目类别:
A phase I clinical study of adoptive transfer of regulatory T cells (Tregs) and low-dose interleukin-2 (IL-2) for the treatment of chronic graft-versus-host disease (GVHD): gene-marking to inform rational combination therapy
调节性 T 细胞 (Treg) 和低剂量白细胞介素 2 (IL-2) 过继转移治疗慢性移植物抗宿主病 (GVHD) 的 I 期临床研究:基因标记为合理的联合治疗提供信息
- 批准号:
nhmrc : GNT1163111 - 财政年份:2019
- 资助金额:
$ 53.39万 - 项目类别:
Project Grants
Determining mechanisms of enhanced antitumor efficacy of four-day expanded Th17 cells for adoptive transfer
确定用于过继转移的四天扩增 Th17 细胞增强抗肿瘤功效的机制
- 批准号:
10462684 - 财政年份:2019
- 资助金额:
$ 53.39万 - 项目类别:
Gene edited lymphoid progenitors for adoptive transfer as a treatment of primary immunodeficiency
基因编辑的淋巴祖细胞用于过继转移作为原发性免疫缺陷的治疗
- 批准号:
398018062 - 财政年份:2018
- 资助金额:
$ 53.39万 - 项目类别:
Research Grants
Overcoming immune suppression in cancer by targeting PSGL-1 in T cells used for adoptive transfer
通过靶向用于过继转移的 T 细胞中的 PSGL-1 克服癌症中的免疫抑制
- 批准号:
9308643 - 财政年份:2017
- 资助金额:
$ 53.39万 - 项目类别:
Overcoming immune suppression in cancer by targeting PSGL-1 in T cells used for adoptive transfer
通过靶向用于过继转移的 T 细胞中的 PSGL-1 克服癌症中的免疫抑制
- 批准号:
9447149 - 财政年份:2017
- 资助金额:
$ 53.39万 - 项目类别:
Targeting Cancer miRNAs by Adoptive Transfer of Programmed B Lymphocytes
通过程序化 B 淋巴细胞的过继转移靶向癌症 miRNA
- 批准号:
8893915 - 财政年份:2014
- 资助金额:
$ 53.39万 - 项目类别:














{{item.name}}会员




